Aparna Patnaik, BS

Massachusetts General Hospital
Boston, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• ORF34-08 - Three Versus Twelve Months of Romosozumab for Postmenopausal Osteoporosis: The Limited Duration Anabolic Therapy (LIDA) Randomized Controlled Trial

  Sunday, June 14, 2026
  3:00 PM - 3:15 PM CT